Atherosclerosis Underlying Development Assessed by Intima-Media Thickness in Patients on Rimonabant

Stopped Company decision taken in light of demands by certain national health authorities

Conditions

• Carotid Artery Plaque
• Arteriosclerosis
• Obesity
• Metabolic Syndrome X

Interventions

• DRUG: Rimonabant
• DRUG: Placebo (for Rimonabant)

Sponsor

Sanofi